Difference between revisions of "Can SCN1A mutations account for SUDEP?"
Jump to navigation
Jump to search
(Created page with "''Nabbout R (2008) Can SCN1A mutations account for SUDEP? – Commentary on Hindocha et al.. Epilepsia 49:2 367–8.'' '''[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1...") |
|||
| Line 1: | Line 1: | ||
| − | + | {{Reference | |
| − | + | |reference= | |
| + | |||
| + | Nabbout R (2008) Can SCN1A mutations account for SUDEP? – Commentary on Hindocha et al.. Epilepsia 49:2 367–8. | ||
| + | |||
| + | |url= | ||
| + | |||
| + | http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2007.01439_5.x/abstract | ||
| + | |||
| + | |abstract= | ||
'''First Paragraph:''' The standardized mortality ratio (SMR; the ratio of ob-served number of deaths in a population to that expected,based on age and sex-specific mortality rates in a referencepopulation) in population-based studies of epilepsy is 2–3.This increased mortality is largely related to the etiology ofthe epilepsy. Most fatalities in patients with chronic, ther-apy resistant epilepsy seem to be seizure-related and oftensudden unexpected deaths (SUDEP). | '''First Paragraph:''' The standardized mortality ratio (SMR; the ratio of ob-served number of deaths in a population to that expected,based on age and sex-specific mortality rates in a referencepopulation) in population-based studies of epilepsy is 2–3.This increased mortality is largely related to the etiology ofthe epilepsy. Most fatalities in patients with chronic, ther-apy resistant epilepsy seem to be seizure-related and oftensudden unexpected deaths (SUDEP). | ||
| − | = | + | |keywords= |
| + | |||
| + | |||
| + | |context= | ||
*Discusses Dravet syndrome, in which ∼75% of patients have SCN1A mutations and there is a high risk of SUDEP, and comments on SCN1A mutations as a potential cause of bradycardia in some patients, but concludes that SCN1A is highly unlikely to cause SUDEP in adult patients. | *Discusses Dravet syndrome, in which ∼75% of patients have SCN1A mutations and there is a high risk of SUDEP, and comments on SCN1A mutations as a potential cause of bradycardia in some patients, but concludes that SCN1A is highly unlikely to cause SUDEP in adult patients. | ||
| − | = | + | |comments= |
| + | |||
| + | |||
| + | }} | ||
Latest revision as of 13:13, 17 June 2019
Nabbout R (2008) Can SCN1A mutations account for SUDEP? – Commentary on Hindocha et al.. Epilepsia 49:2 367–8.
Abstract: First Paragraph: The standardized mortality ratio (SMR; the ratio of ob-served number of deaths in a population to that expected,based on age and sex-specific mortality rates in a referencepopulation) in population-based studies of epilepsy is 2–3.This increased mortality is largely related to the etiology ofthe epilepsy. Most fatalities in patients with chronic, ther-apy resistant epilepsy seem to be seizure-related and oftensudden unexpected deaths (SUDEP).
Keywords:
Context
- Discusses Dravet syndrome, in which ∼75% of patients have SCN1A mutations and there is a high risk of SUDEP, and comments on SCN1A mutations as a potential cause of bradycardia in some patients, but concludes that SCN1A is highly unlikely to cause SUDEP in adult patients.
Comments
Network Graph
Retrieving data for the network graph...